AlphaTON Capital Corp announces a $15 million direct offering for its shares to fund GPU deployments and general purposes.
Quiver AI Summary
AlphaTON Capital Corp, a leading technology company focused on scaling the Telegram super app with a potential market of 1 billion users, announced a definitive agreement to sell 15 million of its ordinary shares at a price of $1.00 per share through a registered direct offering, expected to close around January 14, 2026. The company anticipates raising $15 million from this offering, which will be allocated for scaling GPU deployments for Cocoon AI, working capital, and general corporate purposes. The offering is registered with the SEC under a previously filed shelf registration statement. AlphaTON, operated by an experienced leadership team, also has a strategic focus on various investments and innovations within the TON ecosystem and is involved in drug development for immunotherapy treatments.
Potential Positives
- AlphaTON Capital Corp announced a definitive agreement to purchase 15,000,000 ordinary shares, indicating strong market interest and investment in the company.
- The registered direct offering is expected to generate gross proceeds of $15 million, which will be used for scaling GPU deployments for Cocoon AI and general corporate purposes, highlighting the company's commitment to innovation and growth.
- The company is positioned within a significant addressable market of 1 billion monthly active users of the Telegram super app, suggesting considerable growth potential.
Potential Negatives
- Utilizing a registered direct offering to sell 15 million shares at a low purchase price of $1.00 each may indicate challenges in capital raising and could imply weakened investor confidence.
- The announcement of the offering may lead to dilution of existing shareholders' equity, which can negatively impact stock performance.
- Potential risks and uncertainties related to the offering, including dependency on certain conditions for closure and reliance on market factors, may generate concern among investors regarding the stability of the company's financial outlook.
FAQ
What is the purpose of AlphaTON's recent share offering?
The offering aims to raise $15 million for scaling GPU deployments for Cocoon AI, working capital, and general corporate purposes.
How many shares is AlphaTON offering and at what price?
AlphaTON is offering an aggregate of 15,000,000 ordinary shares at a purchase price of $1.00 per share.
When is the expected closing date for the offering?
The closing of the offering is expected to occur on or about January 14, 2026, pending customary closing conditions.
Who is managing AlphaTON's share offering?
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
Where can I find the prospectus for the offering?
The prospectus will be filed with the SEC and available on their website at www.sec.gov, and by contacting H.C. Wainwright & Co.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ATON Hedge Fund Activity
We have seen 3 institutional investors add shares of $ATON stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 19,119 shares (+19119.0%) to their portfolio in Q3 2025, for an estimated $103,051
- CREDIT AGRICOLE S A removed 68 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $366
- UBS GROUP AG removed 55 shares (-20.4%) from their portfolio in Q3 2025, for an estimated $296
- TOWER RESEARCH CAPITAL LLC (TRC) removed 50 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $269
- WELLS FARGO & COMPANY/MN removed 35 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $188
- SBI SECURITIES CO., LTD. removed 8 shares (-40.0%) from their portfolio in Q3 2025, for an estimated $43
- CITIGROUP INC added 1 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
New York, NY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (NASDAQ: ATON) (“AlphaTON” or the “Company”), the world’s leading public technology company scaling the Telegram super app, with an addressable market of 1 billion monthly active users, today announced that it has entered into a definitive agreement for the purchase of an aggregate of 15,000,000 of its ordinary shares (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per ordinary share (or pre-funded warrant in lieu thereof) in a registered direct offering. The closing of the offering is expected to occur on or about January 14, 2026, subject to the satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The aggregate gross proceeds to the Company from the offering are expected to be $15 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering for scaling GPU deployments for Cocoon AI, working capital and general corporate purposes.
The securities described above are being offered pursuant to a “shelf” registration statement (File No. 333-291921) filed with the Securities and Exchange Commission (“SEC”) on December 3, 2025 and declared effective on December 11, 2025. The offering is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. The prospectus supplement and the accompanying prospectus relating to the securities being offered will be filed with the SEC and be available at the SEC’s website at
www.sec.gov
. Electronic copies of the prospectus supplement and the accompanying prospectus relating to the securities being offered may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by telephone at (212) 856-5711 or e-mail at [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About AlphaTON Capital Corp. (Nasdaq: ATON)
AlphaTON Capital Corp (NASDAQ: ATON) is the world’s leading technology public company scaling the Telegram super app, with an addressable market of 1 billion monthly active users while managing a strategic reserve of digital assets. The Company implements a comprehensive M&A and treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, AlphaTON provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram’s billion-user platform while maintaining the governance standards and reporting transparency of a Nasdaq-listed company. Led by Chief Executive Officer Brittany Kaiser, Executive Chairman and Chief Investment Officer Enzo Villani, and Chief Business Development Officer Yury Mitin, the Company’s activities span network validation and staking operations, development of Telegram-based applications, and strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications.
AlphaTON Capital Corp is incorporated in the British Virgin Islands and trades on Nasdaq under the ticker symbol “ATON”. AlphaTON, through its legacy business, is also advancing first-in-class therapies targeting known checkpoint resistance pathways to achieve durable treatment responses and improve patients’ quality of life. AlphaTON actively engages in the drug development process and provides strategic counsel to guide the development of novel immunotherapy assets and asset combinations. To learn more, please visit https://alphatoncapital.com/ .
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering. These statements relate to future events or AlphaTON’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the development and adoption of artificial intelligence technologies, cryptocurrency market volatility, regulatory developments, technical challenges in infrastructure deployment, and general economic conditions. AlphaTON undertakes no obligation to update any forward-looking statements, except as required by law.
Investor Relations:
AlphaTON Capital Corp
[email protected]
(203) 682-8200
Media Inquiries:
Richard Laermer
RLM PR
[email protected]
(212) 741-5106 X 216